Marie Duranteau, PhD, is an Associate and Program Manager at Sofinnova Partners. As part of the Sofinnova Biovelocita strategy, she actively supports the creation and acceleration of biotech startups in Europe.
Marie joined Sofinnova in 2017 as an analyst in the Sofinnova Capital Strategy , where she focused on early-stage investments, and the sourcing of biopharma opportunities. In her current role, Marie oversees, the collaboration with the Gustave Roussy Institute to foster the development of French oncology start-ups. In addition to her investment role, she also takes on an operational role in the projects and companies Biovelocita invests in and contributes to the translation of innovation alongside scientific founders.
She holds a PhD in cellular biology from Paris Diderot University, carried out at the Jacques Monod Institute and a Master’s in Entrepreneurship from HEC Business School, Polytechnique and the Imagine Institute.